COPZ1 and glioma: The results showed that COPZ1 expression was positively associated with tumor grade and liquefactive necrosis, independent from age, gender, tumor size, and edema, which suggested that COPZ1 could be a potential diagnostic marker for glioma patients (Table 1, p < 0.05).